Search

everythinglearnresearchcommunity

for

Search:↓

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Mouse models help understand alopecia areata and find treatments.

Mice with alopecia areata had wider lymphatic vessels in their skin.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Chemokine signaling is important for hair development.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

FOXO1 is important for wound healing, but its dysfunction in diabetes can slow the healing process.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CD2 might be a new treatment target for patchy alopecia areata.